Business ❯ Corporate Governance ❯ Investor Relations

Stock Market

Public Companies Securities Tesla Securities Fraud Class Action Lawsuits New York Stock Exchange Cryptocurrency Target Corporation Market Analysis Market Capitalization Market Value Decline Tesla, Inc. Stock Price Decline Oracle Corporation Fortinet, Inc. Financial Disclosure Grupo Elektra Mining Companies IPO Performance NASDAQ Twitter Market Manipulation Securities Exchange Act Ultragenyx Pharmaceutical Share Repurchase Securities Violations Financial Reporting

Capricor Faces Multiple Securities Suits After FDA Flags Unapproved Changes to Trial Analysis

FDA classification of Capricor’s resubmission as a major amendment has moved the review deadline to Nov. 22, 2026.

Capricor Hit with Multiple Investor Lawsuits After FDA Questions Unagreed Trial Analysis

PROCEPT Faces Securities Lawsuits as Lead-Plaintiff Deadline Arrives

Multiple Firms Vie to Lead Class Actions After Pentair’s Pool‑Segment Disclosure

Multiple Law Firms File Securities Suits Against Zillow as Lead‑Plaintiff Deadline Arrives

Class Action Targets Cogent Over Alleged Revenue Misstatements

Multiple Firms File Securities Lawsuits After GRAIL’s NHS‑Galleri Trial Failed

Verra Mobility Plunges After Avis Ends Major Contract

Plaintiffs File Class Action Over ChampionX Buybacks That Allegedly Hid Schlumberger Offers

Commvault Faces Securities Class Action Over ARR Shortfall

Coty Investors Face Friday Lead-Plaintiff Deadline as Lawsuits Broaden Over Alleged Disclosure Failures

Law Firms Court Globant Investors Ahead of June 23 Lead‑Plaintiff Deadline

Alight Investors Urged to Seek Lead Role in Securities Suit Ahead of May 15 Deadline

Coty Securities Suit Moves Forward as Firms Seek Lead Plaintiff by May 22

Law Firms Urge monday.com Investors to Seek Lead Role in Securities Case Before May 11

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Corcept Investors Pressed to Seek Lead Role in Securities Suit After FDA Rebuff of Relacorilant

Concorde International Investors Face May 18 Deadline in Securities Class Action